Normal Cognition: Clinical Trials

2 trials for Normal Cognition, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Active not recruiting 1, Completed 1

Follow Normal Cognition: new trials by email Literature Review of Normal Cognition trials Research Report on Normal Cognition

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CYCLE-AD (CYcling to Cease or Limit the Effects of Alzheimer's Disease)
Indoor Cycling (IC) - High Intensity Exercise, Normal Cognition
Not applicableActive not recruitingThe Cleveland Clinic1502021-10-202026-08-12
Ketone Ester Effects on Biomarkers of Brain Metabolism and Cognitive Performance in Cognitively Intact Adults 55 Years Old or Older
Ketone Ester drink, Placebo: isocaloric dextrose drink - Metabolic Syndrome, Normal Cognition
Not applicableCompletedNational Institute on Aging (NIA)992021-06-242026-04-02

Narrower conditions

Alzheimer Disease (1)  ·  Metabolic Syndrome (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Dementia (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Insulin Resistance (1)  ·  Mental Disorders (1)  ·  Metabolic Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurocognitive Disorders (1)  ·  Neurodegenerative Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Tauopathies (1)

Sponsors

National Institute on Aging (NIA) (1)  ·  The Cleveland Clinic (1)

Countries

United States (2)

Top investigators

Dimitrios I Kapogiannis, M.D. (1)  ·  Jay Alberts, PhD (1)  ·  Stephen Rao, PhD (1)

NIH funding

R01AG070736 (1)